Open figure viewer
References
1.
Lin WR, Chen M, Hsu JM, Wang CH: Emphysematous pyelonephritis: patient characteristics and management approach. Urol Int 2014;93:29-33.
2.
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS 2001 International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
3.
Kuzgunbay B, Turunc T, Tokmak N, Turunc T, Dirim A, Aygun C, Ozkardes H: Tailored treatment approach for emphysematous pyelonephritis. Urol Int 2011;86:444-447.
4.
Huang JJ, Chen KW, Ruaan MK: Mixed acid fermentation of glucose as a mechanism of emphysematous urinary tract infection. J Urol 1991;146:148-151.
5.
Julka S: Genitourinary infection in diabetes. Indian J Endocrinol Metab 2013;17(suppl 1): 83-87.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
You do not currently have access to this content.
